Insider · CIK 0001822033
Julie Marie Sorrells
officer
Files at AMCR (Amcor plc). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | AMCR Amcor plc | MOption exercise Ordinary Shares | +567 | - | - | 9,760 | 25 d ago |
| Sep 15, 2026 | AMCR Amcor plc | FTax withholding Ordinary Shares | -164 | $42.25 | $6,929 | 9,596 | 25 d ago |
| Sep 15, 2026 | AMCR Amcor plc | AGrant or award Employee Stock Optionsderivative | +4,973 | $0.00 | $0 | 4,973 | 25 d ago |
| Sep 15, 2026 | AMCR Amcor plc | AGrant or award Restricted Stock Unitsderivative | +854 | $0.00 | $0 | 854 | 25 d ago |
| Sep 15, 2025 | AMCR Amcor plc | AGrant or award Restricted Stock Unitsderivative | +9,467 | $0.00 | $0 | 9,467 | Sep 17, 2025 |
| Sep 15, 2025 | AMCR Amcor plc | AGrant or award Employee Stock Optionsderivative | +69,703 | $0.00 | $0 | 69,703 | Sep 17, 2025 |
| Sep 15, 2025 | AMCR Amcor plc | AGrant or award Restricted Stock Unitsderivative | +8,502 | $0.00 | $0 | 8,502 | Sep 17, 2025 |
| Aug 28, 2025 | AMCR Amcor plc | MOption exercise Ordinary Shares | +2,303 | - | - | 40,836 | Sep 2, 2025 |
| Aug 28, 2025 | AMCR Amcor plc | FTax withholding Ordinary Shares | -123 | $0.00 | $0 | 40,713 | Sep 2, 2025 |
| Aug 28, 2025 | AMCR Amcor plc | MOption exercise Restricted Stock Unitsderivative | -2,303 | $0.00 | $0 | 0 | Sep 2, 2025 |
| Sep 16, 2024 | AMCR Amcor plc | AGrant or award Restricted Stock Unitsderivative | +5,236 | $0.00 | $0 | 0 | Oct 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.